JPMORGAN CHASE & CO - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is and the CUSIP is 12648L901. A total of 5 filers reported holding CTI BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$42,000
-88.8%
10,000
-84.1%
0.00%
Q2 2022$376,00063,0000.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q2 2022
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 261,500$1,561,0000.00%
JANE STREET GROUP, LLC 235,800$1,408,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
SIMPLEX TRADING, LLC 16,200$96,0000.00%
JPMORGAN CHASE & CO 63,000$376,0000.00%
View complete list of CTI BIOPHARMA CORP shareholders